Monoclonal anti-annexin a3 antibodies for the detection of...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) C07K 16/18 (2006.01) C07K 16/30 (2006.01) C12N 5/00 (2006.01)

Patent

CA 2654330

The present invention relates to a method for the diagnosis of prostate carcinoma comprising the determination of annexin A3, particularly of extracellular annexin A3 with highly specific antibodies, particularly with monoclonal antibodies. The present invention further refers to a test reagent comprising such antibodies.

La présente invention concerne un procédé pour le diagnostic du carcinome prostatique comprenant le dosage de l'annexine A3, notamment de l'annexine A3 extracellulaire aux anticorps hautement spécifiques, notamment monoclonaux. La présente invention concerne également un réactif test comprenant de tels anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal anti-annexin a3 antibodies for the detection of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal anti-annexin a3 antibodies for the detection of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal anti-annexin a3 antibodies for the detection of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2002126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.